Fashioning drugs for stroke.
Ted Weita
TW
Lai
Yu Tian
YT
Wang
D000818:Animals; D016923:Cell Death / Q000187:drug effects* / Q000502:physiology; D000076122:Disks Large Homolog 4 Protein; D015195:Drug Design; D051528:Guanylate Kinases; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D018696:Neuroprotective Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D020521:Stroke / Q000150:complications / Q000188:drug therapy*
D000076122:Disks Large Homolog 4 Protein; C501447:Dlg4 protein, mouse; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D018696:Neuroprotective Agents; D016376:Oligonucleotides, Antisense; D016194:Receptors, N-Methyl-D-Aspartate; D052248:Nitric Oxide Synthase Type I; D051528:Guanylate Kinases